Form 4: Strata Critical Medical Grants CAO 11,844 RSUs

Strata Critical Medical, Inc. granted its Chief Accounting Officer, Amir Cohen, 11,844 fully vested Restricted Stock Units.

Summary

• Amir Cohen, Chief Accounting Officer of Strata Critical Medical, Inc. (SRTA), was granted 11,844 shares of Class A common stock, with a reported transaction date of August 29, 2025.
• These shares represent fully vested Restricted Stock Units (RSUs) with a $0 acquisition price.
• The effectiveness of this RSU grant is contingent upon the completion of the previously announced sale of the Issuer's Passenger business to Joby Aero, Inc., pursuant to an Equity Purchase Agreement dated August 1, 2025.
• Following this future transaction, Amir Cohen will beneficially own 103,760 shares directly.

Sentiment

Score: 7

Explanation: The grant of fully vested RSUs to a key executive is a positive for the executive and a standard, expected compensation event for the company, aligning interests. The contingency on a business sale completion adds a minor element of uncertainty but is part of a larger strategic move.

Positives

• Grant of 11,844 fully vested Restricted Stock Units (RSUs) to Chief Accounting Officer Amir Cohen, aligning executive interests with shareholder value.
• The RSUs are fully vested, indicating immediate ownership upon effectiveness, providing a strong incentive.

Risks

• The effectiveness of the RSU grant, and thus the actual acquisition of shares by the reporting person, is contingent upon the future completion of the sale of the Passenger business to Joby Aero, Inc., introducing a dependency risk on that transaction.

Future Outlook

The grant of Restricted Stock Units to the Chief Accounting Officer, with a transaction date of August 29, 2025, is explicitly stated to become effective upon the completion of the previously announced sale of the Issuer's Passenger business to Joby Aero, Inc. This highlights a key future strategic milestone and the company's ongoing efforts to finalize this divestiture.

Industry Context

This filing reflects a standard executive compensation practice (RSU grant) tied to a strategic corporate event (business divestiture). Such grants are common incentives to retain key personnel during significant corporate transitions, ensuring alignment with long-term company objectives and successful completion of strategic initiatives.

Related Party Transactions

• Grant of 11,844 fully vested Restricted Stock Units to Amir Cohen, the Chief Accounting Officer, which is a transaction between the company and a key executive.

Stakeholder Impact

• Shareholders: The grant of RSUs to a key executive aims to align management's interests with long-term shareholder value, particularly in the context of a strategic divestiture. It represents a potential future dilution of existing shares upon settlement, though typically planned for.
• Employees: The grant to a senior executive may signal stability in leadership during a period of corporate transition.

Next Steps

• Completion of the sale of Strata Critical Medical, Inc.'s Passenger business to Joby Aero, Inc.
• Settlement of the granted Restricted Stock Units in shares of the Issuer's common stock upon the sale's completion.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event (RSU grant) tied to a previously announced strategic divestiture. While positive for executive alignment, it does not provide new fundamental information to warrant a change in investment thesis. Investors should continue to hold and monitor the progress of the underlying business sale and overall company performance.

Keywords

Strata Critical Medical, SRTA, Amir Cohen, Restricted Stock Units, RSU, Equity Grant, Executive Compensation, Form 4, Insider Transaction, Joby Aero